Enveric Biosciences ENVB
NASDAQ ENVB
$1.51 +0.07 (+4.86%)
At close: Oct 21, 2026 · 4:00 PM EDT

Enveric Biosciences (ENVB) Operating Leases (2019 - 2022)

Updated

Enveric Biosciences (ENVB) recorded Operating Leases of $9,871 in Q2 2022, down 75.4% from the prior quarter.

Analysis

Enveric Biosciences (ENVB) Operating Leases (2019 - 2022) Analysis & Trends

At the end of FY2021, Enveric Biosciences reported Operating Leases of $68,861.

  • Across earlier years, Operating Leases came in at $169,897 in FY2019.
  • The Q2 2022 figure is the lowest quarterly Operating Leases in data going back to Q2 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Enveric Biosciences 6.02 Mn -15.62 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 9,871.00
Mar 31, 2022 40,117.00
Dec 31, 2021 68,861.00
Sep 30, 2020 678,272.00
Jun 30, 2020 708,237.00
Dec 31, 2019 169,897.00
Sep 30, 2019 198,522.00
Jun 30, 2019 230,377.00
API Access

Enveric Biosciences Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=ENVB&period=max&api_key=YOUR_API_KEY